Overview

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Status:
Terminated
Trial end date:
2004-06-01
Target enrollment:
0
Participant gender:
All
Summary
Intravenous- injection of beta-1,3-glucan in human is known to induce T helper type 1 response, while oral uptake did not. It was examined whether superfine dispersed beta-1,3-glucan (SDG) contrived to absorbed by intestinal mucosa would alleviate allergic symptoms by per-oral ingestion
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Meiji University of Oriental Medicine
Collaborator:
Kyoto Prefectural University of Medicine
Treatments:
Beta-1,3-glucan
Criteria
Inclusion Criteria:

- history of seasonal allergic conjunctivitis with or without rhinitis in spring
(Japanese cedar pollen season) every year

- positive allergen specific IgE (> 30 IU/ml) or positive skin prick test result (wheal
diameter > 3mm) to Japanese cedar, Orchard Grass pollen, or house dust-mite extract

Exclusion Criteria:

- Patients who had undergone immunotherapy in the previous 5 years

- a history of other immunological or medically relevant diseases